Sagimet BiosciencesSGMT

那斯達克 · USD
10.86
+0.15
(+1.40%)
收盤 09/10 03:59 (UTC+8)
盤後 
10.94 
+0.08 
(+0.74%)
09/10 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
15,81811,71310,76514,33411,92519,865--10,5898,768
研發費用
11,5356,9956,7349,7307,24815,34214,21612,6536,3135,262
推銷及管理費用
4,2834,7184,0314,6044,6774,5233,9794,2494,2763,506
非經常性項目費用
----------
其他營業費用
----------
營業利益
-15,818
-11,713
-10,765
-14,334
-11,925
-19,865
-18,195
-16,902
-10,589
-8,768
其他收入及費用
1,8651,0631,1971,4261,5391,6891,9942,2832,4712,139
利息費用
----------
稅前純益
-13,953
-10,650
-9,568
-12,908
-10,386
-18,176
-16,201
-14,619
-8,118
-6,629
所得稅
----------
稅後純益
-13,953
-10,650
-9,568
-12,908
-10,386
-18,176
-16,201
-14,619
-8,118
-6,629
基本每股稅後盈餘(元)
-0.26-0.33-0.29-0.40-0.32-0.56-0.50-0.45-0.25-0.23
稀釋每股稅後盈餘(元)
-0.24-0.33-0.30-0.40-0.32-0.56-0.50-0.47-0.25-0.23
基本平均股數(千股)
53114.0032559.0032521.0032464.0032195.0032195.0032195.0032143.0031913.0029039.00
稀釋平均股數(千股)
53114.0032559.0032521.0032464.0032195.0032195.0032195.0032143.0031913.0029039.00
還原基本每股稅後盈餘(元)
-0.26-0.33-0.29-0.40-0.32-0.56-0.50-0.45-0.25-0.23
還原稀釋每股稅後盈餘(元)
-0.24-0.33-0.30-0.40-0.32-0.56-0.50-0.47-0.25-0.23
還原基本平均股數(千股)
53,11432,55932,52132,46432,19532,19532,19532,14331,91329,039
還原稀釋平均股數(千股)
53,11432,55932,52132,46432,19532,19532,19532,14331,91329,039
EBITDA(千元)
-13,970-10,790-9,268-12,836-10,612-18,711-16,257-15,146-8,595-6,822

大家都在看

HOT